Terms: = Ovarian cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Staging
832 results:
1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
3. Sentinel Node Mapping in ovarian Tumors: A Study Using Lymphoscintigraphy and SPECT/CT.
Ataei Nakhaei S; Sadeghi R; Mostafavi SM; Treglia G; Hassanzadeh M; Esmaeilpour M; Taheri NS; Farazestanian M
Contrast Media Mol Imaging; 2024; 2024():5453692. PubMed ID: 38435483
[TBL] [Abstract] [Full Text] [Related]
4. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
[TBL] [Abstract] [Full Text] [Related]
5. The significance of lower uterine segment involvement in endometrial cancer.
Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
[TBL] [Abstract] [Full Text] [Related]
6. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.
Jassar A; Hemali N; Bhatnagar A
Indian J Pathol Microbiol; 2024; 67(1):68-73. PubMed ID: 38358191
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
[TBL] [Abstract] [Full Text] [Related]
9. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
[TBL] [Abstract] [Full Text] [Related]
10. Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
Katsanevakis E; Addo-Yobo W; Bharathan B; Loona A; Gan C; Nunns D; Gajjar K
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():105-110. PubMed ID: 38237307
[TBL] [Abstract] [Full Text] [Related]
11. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
Chandy RG; Thomas V; Sebastian A; Mani T; Thomas A; Joel A; Ram TS; Peedicayil A
Indian J Cancer; 2023 Oct; 60(4):475-485. PubMed ID: 38185864
[TBL] [Abstract] [Full Text] [Related]
12. Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
Vasta FM; Cormio G; Cassani C; Bergamini A; Scarfone G; Ferrandina G; De Vivo R; Marinaccio M; Danese S; Raspagliesi F; Pignata S; Mangili G
Gynecol Oncol; 2024 Feb; 181():28-32. PubMed ID: 38104526
[TBL] [Abstract] [Full Text] [Related]
13. Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY).
Nero C; Bizzarri N; Di Berardino S; Sillano F; Vizzielli G; Cosentino F; Vargiu V; De Iaco P; Perrone AM; Vizza E; Chiofalo B; Uccella S; Ghezzi F; Turco LC; Corrado G; Giannarelli D; Pasciuto T; Zannoni GF; Fagotti A; Scambia G
Eur J Cancer; 2024 Jan; 196():113435. PubMed ID: 38006759
[TBL] [Abstract] [Full Text] [Related]
14. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
[TBL] [Abstract] [Full Text] [Related]
15. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
[TBL] [Abstract] [Full Text] [Related]
16. Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation.
Ghanem AI; Bhatnagar A; Elshaikh M; Hijaz M; Elshaikh MA
Am J Clin Oncol; 2023 Dec; 46(12):537-542. PubMed ID: 37679878
[TBL] [Abstract] [Full Text] [Related]
17. Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary.
Mazina V; Devins K; Philp L; Bercow AS; James K; Bregar A; Sisodia RC; Oliva E; Del Carmen M
Int J Gynecol Cancer; 2023 Sep; 33(9):1434-1439. PubMed ID: 37567599
[TBL] [Abstract] [Full Text] [Related]
18. [
Chen J; Xu K; Li C; Tian Y; Li L; Wen B; He C; Cai H; He Y
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4064-4076. PubMed ID: 37526694
[TBL] [Abstract] [Full Text] [Related]
19. Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study.
Shigeta S; Shimada M; Tsuji K; Watanabe Z; Tanase Y; Matsuo K; Nakanishi T; Saito T; Aoki D; Mikami M
Sci Rep; 2023 Jul; 13(1):12020. PubMed ID: 37491468
[TBL] [Abstract] [Full Text] [Related]
20. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
[TBL] [Abstract] [Full Text] [Related]
[Next]
